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Abstract
Background: We evaluate a method for the incorporation of covariates into linkage analysis using
the Genetic Analysis Workshop 14 simulated data. Focusing on a randomly chosen replicate (42)
we investigated the effect of the 12 subclinical phenotypes, sex, population, and parent-of-origin on
the linkage signal from a model-free linkage analysis of Kofendrerd Personality Disorder.
Results: We detected a linkage peak on chromosome 1, at about 175 cM, which varied depending
upon individuals' status for subclinical phenotype b. A linkage peak on chromosome 3 (310 cM) was
found not to depend upon subclinical phenotype status. Further peaks were found on
chromosomes 5 (12 cM), 9 (4 cM), and 10 (95 cM), depending on the status of subclinical
phenotypes a, k, and c/d/g, respectively.
Conclusion: Retrospective comparison of our results with the simulation model showed correct
identification of disease loci D1-5 on chromosomes 1, 3, 5, 9 and 10, respectively.
Background
We chose to analyze all four populations of replicate 42
from the simulated data set. All analyses were performed
without knowledge of the simulation model. The aim of
the analysis was to utilize the information on the subclin-
ical phenotypes of Kofendrerd Personality Disorder
(KPD), sex, population, and parent-of-origin in a linkage
analysis. Including covariates in the analysis allowed us to
investigate models, such as locus heterogeneity, that give
rise to different subclinical phenotypes within KPD. We
present the results of our analyses and a retrospective
comparison with the simulation model.
Methods
We began by screening the genome for linkage to KPD.
We performed separate scans of the microsatellites and
the single-nucleotide polymorphism (SNP) data using the
Zlr  test statistic from ALLEGRO [1], with the "pairs"
option and exponential model. Pedigrees with more than
17 individuals were trimmed to permit analysis with the
software. We then examined the effect of the covariates on
the linkage peaks. To do this we fitted subclinical pheno-
type, sex, population, and parent-of-origin status as cov-
ariates in a model-free linkage analysis of the
microsatellite marker data. We also looked for interac-
tions between linkage peaks using this approach.
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Linkage analysis using covariates
Likelihood construction
The multipoint likelihood of the marker data of an
affected relative pair at any point in the genome is given
by
where zj is the (unknown) probability that an affected rel-
ative pair share j alleles identically by descent (IBD), and
fij,  are the prior and posterior (conditional on the
observed marker data) probabilities that pair i shares j
alleles IBD [2,3]. These were obtained for each pair at 1-
cM intervals with and without parental specific allele shar-
ing estimates using MERLIN [4] and ALLEGRO [1], respec-
tively. Let pFS be the probability that a pair of affected full
siblings share a given parental allele IBD. Following the
suggestion of Rice [5,6], in the absence of a parent-of-ori-
gin effect the probabilities of sharing paternal and mater-
nal alleles IBD were assumed to be equal and
independent. Then z0 = (1 - PFS)2, z1 = 2 pFS (1 - P FS), and
. Similar formulae apply for double-first-cousin
pairs.
Other types of relative pair, R, can only share 0 or 1 allele
IBD. For these, z0 = 1 - PR, z1 = PR, and z2 = 0 (where PR is
the IBD probability for affected relative pairs of type R).
Inclusion of categorical covariates
The effect of a binary covariate on the IBD sharing proba-
bilities may be investigated by modelling PR in a logistic
regression framework including a 3-level factor β with lev-
els corresponding to the status of the pair with respect to
the covariate (-/-, -/+ or +/+, where - denotes absence and
+ presence of the covariate in an individual). That is,
where OR is a fixed offset, ensuring that PR takes the correct
value for a relative pair of type R in the absence of linkage
(i.e., all coefficients in the regression = 0). Under the null
hypothesis of no covariate effect, α is a measure of the
divergence of IBD from the null in the sample as a whole.
The subscript k indexes the status of the particular relative
pair with respect to the covariate. Multiple pairs from the
same pedigree were analysed as if they were independent,
with parameters α and β in common. To ensure identifia-
bility of the parameters, β-/- was set to zero (making α a
measure of IBD divergence from the null in -/- pairs). The
degree of IBD sharing for the discordant (-/+) pairs was
constrained to be less than or equal to the maximum IBD
in the concordant pairs, to ensure that the model makes
sense biologically. Each of the subclinical phenotypes (a -
l) was modelled in this way, as was sex (male denoted by
-, female denoted by +). Population membership was
modelled as a four-level factor, with one level for each
population (the first was set to zero). The total number of
affected relative pairs in each category is shown in Table 1.
One might expect a gene that modified the expression of
a binary covariate (e.g., subclinical phenotype outcome)
in individuals affected with KPD (but not KPD risk itself),
to present increased sharing in -/- or +/+ pairs (or both),
with -/+ pairs showing reduced sharing. A gene that acts to
cause KPD with a particular set of covariate values (- or +)
would cause increased sharing in either -/- or +/+ pairs,
with the effects on IBD in the pairs of other types being
unclear (dependent on penetrances, gene frequencies,
etc.). Caution should be applied to the interpretation of
the allele sharing estimates as the differences could arise
from a number of reasons.
Inclusion of quantitative covariates
Locus × locus interactions between the peaks were investi-





































Table 1: The total number of affected relative pairs in each covariate category
Covariate Categories Covariate Categories
Phenotype -/- -/+ +/+ Phenotype -/- -/+ +/+
A 517 161 74 i 527 211 14
B 129 180 443 j 561 173 18
c/d/g 165 186 401 k 268 221 263
e/f/h 0 0 752 l 602 122 28
AI DA KA NY
Population 154 143 161 294 Sex 173 373 206
Subclinical phenotypes (and sex) are split into -/-, -/+ and +/+, where - and + indicate absent (male) and present (female), respectively. Population 
splits the data into four groups; AI (Aipotu), DA (Danacaa), KA (Karangar) and NY (New York City).BMC Genetics 2005, 6:S45
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each pair at one location on a different chromosome (hav-
ing subtracted the expected value in the absence of link-
age) as a quantitative covariate in the logistic regression
for IBD at the peak of interest [7]. This is then repeated for
a number of locations in the region surrounding the locus
being conditioned on to allow for the fact that linkage
peaks are often some distance from disease loci [8]. The
test statistic was taken to be the increase in maximum
LOD score over the whole region investigated (covering
both linkage peaks). For completeness, the hypothesis of
an interaction between two peaks was investigated with
two tests, i) peak 1 conditional on peak 2, and ii) peak 2
conditional on peak 1. In general, these give similar
results.
Inclusion of parent-of-origin covariate
Finally, parent-of-origin effect was modelled in affected
sibling pairs only by splitting the prior and posterior
probabilities, fi1 and  , of sharing 1 allele IBD into com-
ponents reflecting whether the paternal or maternal allele
was shared. The IBD probabilities for affected pairs were
expressed in terms of IBD probabilities for the paternal
(ppat) and maternal (pmat) alleles (e.g., z2 = ppat pmat), with
the test statistic for parent-of-origin effect given by a like-
lihood-ratio test of ppat = pmat.
Test statistic and significance levels
To test for effects of categorical or quantitative covariates,
the likelihood was maximized with respect to α alone at
each position x, to give  , and to both α
and β, giving  . The ratio of the maximum
likelihoods on the chromosome, with and without the
covariate of interest, gives a LOD score, which was used as
the test statistic
We allowed the location of the maximum likelihood to
change when the covariate was added. This reflects the fact
that linkage peaks from standard analyses are often some
distance from the true disease locus [8]. Incorporating the
covariate may thus give a more accurate estimate of the
disease locus location. Other test statistics are possible, for
example the maximum point-wise likelihood ratio. How-
ever, the relative performance of these test statistics is
unclear at present. Chromosome-wide significance levels
were obtained by keeping the genotypes fixed and ran-
domly permuting individual covariate values among the
affected individuals. Pairwise covariate values were then
calculated and the analysis repeated, thus significance lev-
els reflect the dependency of pairs within a pedigree. To
test for a parent-of-origin effect, the designations of pater-
nal and maternal alleles were randomly swapped for all
affected siblings in a sibship. If n replicates are generated
in this manner, of which r give a test statistic greater than
that in the actual data, the chromosome-wide p-value is
estimated by (r + 0.5)/(n + 0.5).
For the test statistic chosen for this analysis, it was not pos-
sible to obtain a genome-wide significance level for cov-
ariate effects because this depends not only on the
increase in LOD score given by the covariate, but also on
the linkage evidence present without allowing for the cov-
ariate, i.e., based on  . For example, an
increase in LOD score of 2 to 3 is more significant than
from 0 to 1 because the former is likely to occur by chance
(in the absence of covariate effects) only in a linkage peak
region, whereas the latter could occur anywhere on the
chromosome. An estimate of genome-wide significance
for a given chromosome, allowing for multiple testing,
involves a joint Bonferroni-type adjustment for the rela-
tive length of the chromosome and the number of covari-
ate tests conducted.
The subclinical phenotypes c, d, and g were indistinguish-
able in the affected individuals and e, f, and h were all
present in the affected individuals and hence provided no
useful information for analysis. Therefore, we have carried
out 10 covariate analyses on each chromosome (subclini-
cal phenotypes a, b, c, i, j, k, and l, sex, population and
parent-of-origin). The interaction analyses were carried
out between identified peak regions and hence were
treated separately.
Results
We found genome-wide significant linkage peaks on chro-
mosomes 1 (max Zlr = 4.97 at 177 cM), 3 (max Zlr = 5.58
at 310 cM), 5 (max Zlr = 5.11 at 12 cM) and 9 (max Zlr =
6.04 at 4 cM). On chromosome 1 the peak was narrower
with the 3-cM SNP map than with the microsatellite map,
but this effect was not seen for the other peaks.
The linkage signal on chromosome 1 was found to
increase substantially when the subclinical phenotype b
was fitted as a covariate in the relative pair covariate link-
age analysis, a LOD of 7.07 being increased to 14.29
(chromosome-wide  p  < 0.0001, genome-wide p  =
0.0097). The linkage evidence appeared to come entirely
from the +/+ pairs (IBD = 0.66, compared to 0.49, 0.48
from the -/-, -/+ pairs). A similar effect was found on chro-
mosome 5 with the subclinical phenotype a (LOD
ˆ fi1
Lx  αβ () = () ,0
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increased from 4.90 to 10.05, chromosome-wide p  <
0.0001, genome-wide p = 0.0096), with the linkage com-
ing from the -/- pairs (IBD-/- = 0.62, IBD-/+ = 0.44, IBD+/+ =
0.51), and chromosome 10 (at 95 cM) with the subclini-
cal phenotype c (LOD increased from 1.04 to 5.31, IBD-/-
= 0.63, IBD-/+ = 0.43, IBD+/+ = 0.53, chromosome-wide p =
0.0004, genome-wide p = 0.063). On chromosome 9, the
LOD increased from 7.65 to 18.13 with subclinical phe-
notype k (chromosome-wide p < 0.0001, genome-wide p
= 0.0096), with increased sharing in both the -/- and +/+
pairs (IBD-/- = 0.63, IBD-/+ = 0.42, IBD+/+ = 0.67). No
genome-wide significant effect of subclinical phenotype
was observed on chromosome 3. No significant results
were obtained for the analyses considering differences in
IBD owing to sex, population, parent-of-origin, or interac-
tions between the four identified linkage peaks. For each
analysis, the maximum LOD score is presented in Table 2.
Discussion
Retrospective comparison of our results with the simula-
tion model showed correct identification of disease loci
D1-5 on chromosomes 1, 3, 5, 9, and 10, respectively. D1
influences phenotypes P1 and P3, which both have sub-
clinical phenotype b, confirmed by the increased sharing
we observed in the b+/+ affected pairs. D2 influences all
three phenotypes, P1-3, with one or two of the subclinical
phenotype b and c in a somewhat complicated manner.
D2 also influences subclinical phenotype k. We observed
increased IBD in the k+/+ pairs (chromosome-wide p =
0.016), but this was not significant at the genome-wide
level.
D2 and D3 together help to produce P2 and P3, with D3
also influencing subclinical phenotype a. We detected the
association of subclinical phenotype a with D3, finding
elevated sharing in the -/- pairs and decreased sharing in
the -/+ pairs. D4 is related to P2 through subclinical phe-
notype c and P3 through b and c. D4 also influences sub-
clinical phenotype k, which we observed through
increased IBD sharing in pairs concordant for k.
No interactions were found between loci D1-4 when
examining relative pairs concordantly affected for KPD in
general, or even the relevant phenotype (P1-3). This is
because the penetrances of the low-risk genotype combi-
nations were set to zero, giving a multiplicative model for
interactions. Under such models, IBD sharing at one locus
is independent of that at the other [2]. The D1–D4 inter-
action could be detected by analyzing affected pairs to
which exactly one member had P3 (a negative correlation
in IBD was observed at the two loci). However, the D2–
D3 interaction in P3 and the D1–D2 interaction in P1
were not detected by this method, due to the reduced pen-
etrance of the relevant genotypes. Likewise, no linkage evi-
dence was obtained at D6 (a modifying locus that affects
the penetrance of phenotype P2), even when affected
pairs discordant for P2 were analyzed. These results are
consistent with the observation that affected relative-pair
analysis has low power to detect locus-locus linkage inter-
actions [7].
Conclusion
From analyzing the data blind to the simulation model,
there appear to be five susceptibility genes for KPD,
Table 2: Maximum LOD scores and number of parameters estimated for each covariate analysis on each chromosome
Covariate analysisa Number of 
parameters
Maximum LOD score for each chromosomeb
123456789 1 0
A 3 8.00 3.07 8.67 2.31 10.05 2.31 2.03 2.56 8.77 1.35
B3 14.29 3.00 8.26 1.93 4.91 2.71 2.87 1.49 9.76 1.67
c/d/g 3 8.11 2.67 8.45 1.82 6.50 2.44 1.71 2.60 8.75 5.31
e/f/h 3 7.07 2.03 7.49 0.52 4.90 1.53 0.71 0.59 7.65 1.04
I 3 7.72 2.20 8.41 1.64 7.34 2.62 1.33 2.07 8.45 1.51
J 3 7.22 2.94 7.73 2.83 6.97 3.37 1.28 1.74 9.30 1.57
K 3 7.35 2.69 9.43 2.38 5.46 2.24 2.11 2.77 18.13 1.33
L 3 7.53 2.61 9.38 2.01 5.25 2.01 1.28 1.58 9.92 1.65
Sex 3 7.30 4.18 7.67 2.26 5.40 1.81 1.26 1.74 8.01 2.09
Population 4 8.55 3.89 7.73 1.62 5.72 2.67 2.49 1.88 9.25 3.42
Univariate (ARP) 1 7.07 2.03 7.49 0.52 4.90 1.53 0.71 0.59 7.65 1.04
Parent-of-origin (ASP) 2 5.77 2.42 8.05 0.57 3.90 2.31 1.88 1.21 7.48 2.00
Univariate (ASP) 1 4.84 1.75 7.14 0.41 3.75 2.29 0.62 0.45 7.35 1.67
a All analyses, except for parent-of-origin, were based on affected relative pairs (ARP). Parent-of-origin was an affected sibling pair (ASP) analysis.
b The LOD scores marked in bold indicate the analyses that showed an increase in maximum LOD score from the baseline univariate to the 
covariate LOD that reached genome-wide significance. Chromosome 10, subclinical phenotype c/d/g was genome-wide significant at p = 0.063 and 
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located on chromosomes 1, 3, 5, 9, and 10. Those on
chromosomes 5 and 10 appear to influence disease only
in the absence of subclinical phenotypes a and c/d/g
respectively. The locus on chromosome 1 influences dis-
ease only in individuals with subclinical phenotype b,
whereas that on chromosome 9 appears to have two vari-
ants, one giving rise to the presence of subclinical pheno-
type k in affected individuals, the other to its absence. No
subclinical phenotype was found to have a significant
genome-wide effect on the linkage of KPD to chromo-
some 3, although k reached chromosome-wide signifi-
cance. Even with knowledge of the simulation model, it
was difficult to detect the locus-locus interactions, sug-
gesting that affected relative pairs give little power for such
analyses.
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